Delivery Order SPE2DB22D2007-SPE2DB23FJ5VF
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $301
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $442 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 closures for 16/20 milliliter vials. The delivery order was issued against the DLA's Pharmaceutical Prime Vendor contract vehicle and performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. No subcontractors or set aside designations...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $180 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 closures for 16/20 milliliter vials. The delivery order is being carried out under the DLA's Pharmaceutical Prime Vendor contract vehicle, which consolidates pharmaceutical procurement for various DOD components. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $166 firm fixed price delivery order by the Defense Logistics Agency to provide 1,562,145,856 closures for 30/40/60 milliliter vials. The delivery order was issued against the DLA's Pharmaceutical Prime Vendor contract vehicle and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No subcontractors or set aside designations...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $266.77 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 units of 16/20 milliliter closure-fitted vials for pharmaceutical use. The delivery order is associated with DLA's prime vendor program and has a period of performance from August 4-7, 2023. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania, supporting DLA's mission...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $832 firm fixed price delivery order by the Defense Logistics Agency to provide 4561364736 closure fits for 16/20 milliliter vials. Performance will take place in Conshohocken, Pennsylvania over a one day period concluding on June 29, 2023. The delivery order was issued against the DLA's Pharmaceutical Prime Vendor contract vehicle to supply pharmaceutical products and services to the Department...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $287,940 firm fixed price delivery order by the Defense Logistics Agency to provide 1-CLIC closures that fit 30/40/60 milliliter drug vials. The closures will be delivered to the agency's location in Conshohocken, Pennsylvania over a four day period beginning September 1, 2023. The delivery order was issued against the DLA's Pharmaceutical Prime Vendor program, which provides pharmaceuticals and...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $238 delivery order by the Defense Logistics Agency to provide 1,560 16/20 milliliter closure-fitted vials. The firm fixed price order is for product delivery by September 11, 2023 in Conshohocken, Pennsylvania under the DLA's Pharmaceutical Prime Vendor contract vehicle. No subcontractors or set aside designations were indicated. The order supports the DLA's medical supply procurement...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $281 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560,000 closures for 16/20 milliliter vials. The delivery order is being carried out under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the closures to be delivered to a DLA facility in Conshohocken, Pennsylvania by July 24, 2023. As a leading provider of pharmaceuticals and other...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $186 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 units of 16/20 milliliter closure-fitted vials for pharmaceutical use. The one-day contract is to be performed in Conshohocken, Pennsylvania under the DLA's Pharmaceutical Prime Vendor program, which consolidates medical commodity procurement for various Department of Defense components. No subcontractors or...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $331.65 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 units of 16/20 ml vial closures to support pharmaceutical distribution needs. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on July 10, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to ensure mission-critical medical supplies are...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ5VFDelivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $301 firm fixed price delivery order by the Defense Logistics Agency to provide 1,560 closures for 16/20 milliliter vials. The delivery order was issued against the DLA's Pharmaceutical Prime Vendor contract vehicle and performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. No subcontractors or set aside designations were identified. The Pharmaceutical Prime Vendor program supports the DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide.
Generated 12/19/23, 7:31 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $301 | 9/6/23 |